Skip to main content
Log in

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

As central 5-hydroxytryptamine (5-HT) is attenuated for a period following a single dose of MDMA (“ecstasy”) and low 5-HT is associated with aggression, then MDMA users may be more aggressive in the days following an acute dose of the drug.

Objective

This study therefore aimed to determine if acute use of MDMA is associated with aggression 4 and 7 days later.

Methods

Twenty-nine MDMA users and 32 controls were compared on self-rated aggression and depression on the night of drug use (day 0), 4 and 7 days later. On day 4, participants performed an interpretative bias task in which they processed ambiguous sentences that could be interpreted in either an aggressive or neutral way (e.g. “The painter drew the knife”).

Results

MDMA users had faster response times in completing ambiguous aggressive sentences than neutral sentences; controls showed the opposite pattern of performance. In a subsequent recognition task, MDMA users were more confident in judging, and responded faster to, aggressive than neutral sentences; controls again showed the opposite pattern of effects. The level of aggressive interpretative bias positively correlated with extent of MDMA use. Midweek, MDMA users had higher self-rated aggression and depression scores than controls; on day 7, scores of both groups were similar.

Conclusions

MDMA users display a cognitive bias towards interpreting ambiguous information in an aggressive way a few days after taking the drug. Self-rated mid-week low mood and mid-week aggression do not persist 7 days after use of the drug. This pattern of results is consistent both with the acute and residual effects of MDMA on central 5-HT and with the notion that 5-HT plays a role in modulating human aggression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Beck AT (1978) The Beck Depression Inventory (BDI). The Psychological Corporation, Harcourt Brace Jovanovitz

  • Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218

    Google Scholar 

  • Bond AJ, Lader MH (1986) A method to elicit aggressive feelings and behaviour via provocation. Biol Psychol 22:69–79

    CAS  PubMed  Google Scholar 

  • Bond AJ, Wingrove J, Critchlow DG (2001) Tryptophan depletion increases aggression in women during the premenstrual phase. Psychopharmacology 156:477–480

    Article  CAS  PubMed  Google Scholar 

  • Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131–139

    CAS  PubMed  Google Scholar 

  • Buss AH, Perry M (1992) The aggression questionnaire. J Person Soc Psychol 63:452–459

    CAS  Google Scholar 

  • Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R. (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects. J Clin Psychopharmacol 20:455–466

    Article  CAS  PubMed  Google Scholar 

  • Cleare AJ, Bond AJ (1995) The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology 118:72–81

    Google Scholar 

  • Cleare AJ, Bond AJ (1997) Does central serotonergic function correlate inversely with aggression? A study using d-fenfluramine in healthy subjects. Psychiatry Res 69:89–95

    CAS  PubMed  Google Scholar 

  • Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46:587–599

    CAS  PubMed  Google Scholar 

  • Copello AG, Tata PR (1990) Violent behaviour and interpretative bias: an experimental study of the resolution of ambiguity in violent offenders. Br J Clin Psychol 29:417–428

    PubMed  Google Scholar 

  • Cowen PJ (1991). Serotonin receptor subtypes: implications for psychopharmacology. Br J Psychiatry Suppl 12:7–14

    PubMed  Google Scholar 

  • Curran HV (2000) Is MDMA (ecstasy) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 42:34–41

    CAS  PubMed  Google Scholar 

  • Curran HV, Travill RA (1997) Mood and cognitive effects of 3,4 methylenedioxymethamphetamine (MDMA, “ecstasy”): weekend “high” followed by midweek “low”. Addiction 92:821–831

    Article  CAS  PubMed  Google Scholar 

  • Curran HV, Verheyden SL (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (“ecstasy”) is highly correlated with human memory function. Psychopharmacology 169:91–103

    Article  CAS  PubMed  Google Scholar 

  • Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delssignore R (1998) Serotonergic function after 3,4 methylenedioxymethamphetamine (“ecstasy”) in humans. Int Clin Pharmacol 13:1–9

    CAS  Google Scholar 

  • Gerra G, Zaimovic A, Ampollinin R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F (2001) Experimentally induced aggressive behaviour in subjects with 3,4 methylenedioxymethamphetamine (“ecstasy”) use history. Psychobiological correlates. J Subst Misuse 13:471–491

    Article  CAS  Google Scholar 

  • Goodwin GM, DeSouza RJ, Green AR (1985) Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317:531–533

    CAS  PubMed  Google Scholar 

  • Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4 methylenedioxymethamphetamine (MDMA or ecstasy). Psychopharmacology 119:247–260

    CAS  PubMed  Google Scholar 

  • Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161–168

    CAS  PubMed  Google Scholar 

  • Linnoila M, Virkkunen M (1992) Biologic correlates of suicidal risk and aggressive behavioural traits. J Clin Psychopharmacol 12:19S–20S

    CAS  PubMed  Google Scholar 

  • Linnoila M, Virkkunen M, George T, Higley D (1993) Impulse control disorders. Int Clin Psychopharmacol 8:53–56

    Google Scholar 

  • McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”): a controlled study in humans Neuropsychopharmacology 10:129–138

  • McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) J Neurochem 541:14–22

    Google Scholar 

  • Morgan MJ (1998) Recreational use of ecstasy (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264

    Article  CAS  PubMed  Google Scholar 

  • Novaco RW (1978) Anger and coping with stress: Cognitive behavioural intervention. In: Foreyt JP, Rathjen P (eds) Cognitive behavioural therapy: research and application. Plenum Press, New York/London

  • Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261–268

    Article  CAS  PubMed  Google Scholar 

  • Rattray M (1991) Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem 26:77–87

    CAS  PubMed  Google Scholar 

  • Schmidt C J, Wu L, Lovenberg W (1986) Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. Eur J Pharmacol 124:175–178

    CAS  PubMed  Google Scholar 

  • Smith KA, Fairburn CG, Cowen PJ (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349:915–919

    CAS  PubMed  Google Scholar 

  • Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of “ecstasy” users and their experiences with the drug. Br J Addict 87:1161–1172

    CAS  PubMed  Google Scholar 

  • Verheyden SL, Hadfield J, Calin T, Curran HV (2002) Sub-acute effects of MDMA (3,4 methylenedioxymethamphetamine, “ecstasy”) on mood: evidence of gender differences. Psychopharmacology 161:23–31

    Article  CAS  PubMed  Google Scholar 

  • Vollenweider FX, Gamma A, Liechti M, Huber T (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241–251

    Article  CAS  PubMed  Google Scholar 

  • Young SN, Leyton M (2002) The role of serotonin in human mood and social interaction: insight from altered tryptophan levels. Pharmacol Biochem Behav 71:857–865

    Google Scholar 

  • Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None of the authors have any interest, financial or otherwise, that might potentially bias their work. We thank Dr. Suzanne Verheyden for comments on an earlier draft of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Valerie Curran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Curran, H.V., Rees, H., Hoare, T. et al. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology 173, 425–433 (2004). https://doi.org/10.1007/s00213-003-1713-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1713-6

Keywords

Navigation